These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20001241)

  • 41. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse.
    Inukai T; Yokota S; Okamoto T; Nemoto A; Akahane K; Takahashi K; Sato H; Goi K; Nakazawa S; Sugita K
    Leukemia; 2006 Feb; 20(2):363-5. PubMed ID: 16357830
    [No Abstract]   [Full Text] [Related]  

  • 43. ETV6-RUNX1-positive ALL may be driven by aberrant RAG activity.
    Cancer Discov; 2014 Mar; 4(3):OF15. PubMed ID: 24596209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
    Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
    Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
    Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).
    Lee DS; Kim YR; Cho HK; Lee CK; Lee JH; Cho HI
    Cancer Genet Cytogenet; 2005 Oct; 162(2):176-8. PubMed ID: 16213368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Grausenburger R; Bastelberger S; Eckert C; Kauer M; Stanulla M; Frech C; Bauer E; Stoiber D; von Stackelberg A; Attarbaschi A; Haas OA; Panzer-Grümayer R
    Leuk Lymphoma; 2016 May; 57(5):1163-73. PubMed ID: 26327566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia.
    Attarbaschi A; Mann G; Strehl S; König M; Steiner M; Jeitler V; Lion T; Dworzak MN; Gadner H; Haas OA
    Leukemia; 2007 Mar; 21(3):584-6. PubMed ID: 17215856
    [No Abstract]   [Full Text] [Related]  

  • 51. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
    Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: a genome-wide analysis.
    Emerenciano M; Bungaro S; Cazzaniga G; Dorea MD; Coser VM; Magalhães IQ; Biondi A; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2009 Sep; 193(2):86-92. PubMed ID: 19665068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
    Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
    Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia.
    Niini T; Kanerva J; Vettenranta K; Saarinen-Pihkala UM; Knuutila S
    Haematologica; 2000 Apr; 85(4):362-6. PubMed ID: 10756360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup.
    Soulier J; Trakhtenbrot L; Najfeld V; Lipton JM; Mathew S; Avet-Loiseau H; De Braekeleer M; Salem S; Baruchel A; Raimondi SC; Raynaud SD
    Leukemia; 2003 Aug; 17(8):1679-82. PubMed ID: 12886264
    [No Abstract]   [Full Text] [Related]  

  • 56. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
    Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
    Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
    Moosavi SA; Sanchez J; Adeyinka A
    Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [AML1 gene signal patterns and clinical significance in 337 patients with B-cell acute lymphoblastic leukemia].
    Huang H; Lin Y; Xiong F; Xu H; Wu Y; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):111-2. PubMed ID: 26879433
    [No Abstract]   [Full Text] [Related]  

  • 60. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
    Alpár D; Kajtár B; Kneif M; Jáksó P; László R; Kereskai L; Pajor L
    Cancer Genet Cytogenet; 2007 Feb; 173(1):23-30. PubMed ID: 17284366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.